Maplight Therapeutics, Inc. · NASDAQ:MPLT
Kreitzer Anatol sold 3,316 Maplight Therapeutics, Inc. shares (Form 4)
Traded Apr 15, 2026 · Filed Apr 17, 2026
On Apr 15, 2026, Kreitzer Anatol (Chief Discovery Officer) sold 3,316 Maplight Therapeutics, Inc. shares at US$26.61 for US$88,239, leaving 256,612 shares. Filed Apr 17, 2026 (Form 4).
- Sold
- 3,316 shares
- Price
- US$26.61
- Value
- US$88,239
- Holding after
- 256,612 shares
- Trading plan
- No
- Role
- Chief Discovery Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 15, 2026 | Voting Common Stock | Sale | 3,316 | US$26.61 | 256,612 | Direct |
Source
Related
- Maplight Therapeutics, Inc.
- Kreitzer Anatol
- Maplight Therapeutics, Inc. shareholders
- Form 4 · Kreitzer Anatol · Oct 16, 2026
- Form 4 · Kreitzer Anatol · Aug 19, 2026
- Form 4 · Kreitzer Anatol · Jul 20, 2026
- Form 4 · Kreitzer Anatol · Apr 29, 2026
- Form 4 · Foff Erin Pennock · Oct 16, 2026
- Form 4 · Gillis Jonathan · Oct 16, 2026
- Form 4 · Kroeger Christopher A. · Oct 16, 2026
- Form 4 · Hanson Kristopher · Oct 16, 2026
- Form 4 · Lillie James Woodruff · Oct 16, 2026